What systemic signs and symptoms suggest that a vaginal Candida glabrata infection has become disseminated?

Systemic Signs and Symptoms of Disseminated Candida glabrata Infection

Vaginal C. glabrata infection becoming systemic is extremely rare and typically only occurs in severely immunocompromised patients, but when it does, you should look for fever unresponsive to antibiotics, persistent candidemia despite treatment, and evidence of end-organ involvement including cardiac microabscesses, renal involvement, or hepatosplenic candidiasis.

Key Clinical Indicators of Systemic Spread

Primary Warning Signs

• Persistent fever despite appropriate antibiotic therapy (most common presenting symptom of candidemia)
• Positive blood cultures for C. glabrata (candidemia is the most diagnosed manifestation of invasive disease) 1
• Failure to respond to standard vaginal antifungal therapy

Organ-Specific Manifestations

When C. glabrata disseminates, it can invade previously viable tissue and cause:

Cardiovascular:

• Cardiac microabscesses (documented in severe cases) 2
• Endocarditis (requires focused cardiovascular examination) 3

Renal/Urinary:

• Pyelonephritis with flank pain
• Persistent candiduria despite treatment
• Fungus balls in the collecting system 3

Hepatosplenic:

• Right upper quadrant pain
• Hepatosplenic candidiasis (particularly in neutropenic patients with prolonged fever) 3

Neurological:

• Meningitis (requires neurological examination) 3

Other:

• Prostatitis or epididymo-orchitis (rare) 3

High-Risk Patient Populations

Systemic C. glabrata infection from vaginal sources has been documented in:

• Pregnant women following IVF and embryo transfer with recurrent vaginal candidiasis 4
• Immunosuppressed patients (HIV, diabetes, immunosuppressive medications) 2, 5
• ICU patients with central venous catheters and broad-spectrum antibiotic use 1

Critical Diagnostic Approach

Immediate actions when systemic spread is suspected:

1. Blood cultures (multiple sets) - candidemia is the most frequently diagnosed presentation 1
2. Thorough physical examination focusing on:
   • Cardiovascular system (murmurs, signs of endocarditis)
   • Neurological examination (meningeal signs)
   • Abdominal examination (hepatosplenomegaly, right upper quadrant tenderness)
3. Imaging in high-risk patients:
   • CT abdomen/pelvis for hepatosplenic candidiasis if prolonged neutropenia and persistent fever 3
   • Echocardiography if endocarditis suspected

Important Clinical Caveats

C. glabrata-specific challenges:

• Lacks hyphae/pseudohyphae, making microscopic diagnosis difficult - requires culture confirmation 4
• Innate azole resistance - fluconazole may be ineffective 5, 6
• Non-specific symptoms - fever and malaise are common but not diagnostic 1
• Attributable mortality ~30% for candidemia and disseminated infections 1

When to Escalate Care

Immediately consult infectious disease if:

• Blood cultures positive for C. glabrata
• Persistent fever >72 hours with vaginal C. glabrata and risk factors
• Signs of end-organ involvement
• Immunocompromised host with recurrent vaginal C. glabrata

Treatment note: Systemic C. glabrata requires echinocandins or amphotericin B, NOT fluconazole, due to inherent resistance 3, 7, 1. Early antifungal treatment and central line removal (if present) are cornerstones of reducing mortality 1.